tag@treatmentactiongroup.org

TB

TAG’s Submission to OHCHR for GA78 Report

  • Dorrit Walsh
TAG recently submitted this input for the Office of the High Commissioner on Human Rights (ONHCR) Independent Expert on Foreign Debt and Human Rights thematic report for the UN General Assembly 78 later this year.
Read more

Research in Action Awards 2023

  • Dorrit Walsh
Save the date for Monday, October 19! TAG’s 2023 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world.
Read more
Covers of the two nitrosamines publications on this page.

Nitrosamines and TB Medicines Information Note and Patient FAQs

  • Dorrit Walsh

In 2020, health authorities and drug manufacturers identified a type of chemical impurity called nitrosamines in rifampicin and rifapentine, two essential medicines used in the treatment and prevention of TB. TAG and IMPAACT4TB project partners have developed several materials to…

Read more
cover of publication, black with white and red text that reads: 35 years of Art fo end AIDS

35 Years of Art to End AIDS Exhibition Catalog

  • Dorrit Walsh
TAG is presenting the exhibition “35 Years of Art to End AIDS” at Melissa Morgan Fine Art in Palm Desert, California, from March 17 through April 7, 2023. This exhibit features selected works form our Limited Art Editions collection.
Read more

1/4/6×24 Campaign Videos

  • Dorrit Walsh

All people affected by TB have a right to benefit from scientific progress and to access the best-available short-course regimens for TB prevention and treatment. The 1/4/6x24 Campaign demands that countries and other duty bearers take action to implement the…

Read more

For World TB Day, TB Advocates Demand Universal Access to Shorter, Safer TB Regimens

  • Dorrit Walsh
On March 24, World Tuberculosis (TB) Day offers an opportunity to take stock of global progress against the deadliest disease in human history. This year, we face a sobering reality: since the start of the COVID-19 pandemic, rates of TB infection and death are higher than they’ve been since the early 2000s, setting back an already woefully inadequate effort to end the disease.
Read more
Back To Top